Shared by



Jul 7, 2020 09:30



July 7, 2020 08:20 AM ET (BZ Newswire)

Wedbush analyst David Nierengarten upgrades Unum Therapeutics (NASDAQ:UMRX) from Neutral to Outperform and raises the price target from $1 to $4

I think this is the first time I have traded the exact same stock back to back. Should have just held it but I do not like holding anything overnight. Funny I just finished explaining to someone how I never trade back to back and then I go and do that exact thing. Anyway, I jumped in real quick and scalped out $150 in the first 5 minutes of trading and called it a day.... so far....

Execution detail:

Date/time Symbol Side Price Position
2020-07-07 09:30:53 UMRX buy $2.600 long
2020-07-07 09:34:37 UMRX sell $3.070 long
2020-07-07 09:34:37 UMRX sell $3.070 0

Leave a comment about this trade!

You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes just a few seconds to sign up, and it's free!

View plans, Sign up for free, or Log in